Results for the medicine ocrelizumab:

OCREVUS 300mg 30mg/ml perfusive solution concentrate EGIS ORIGINAL
MEDICINE

Chemical substance: ocrelizumab

ATC code: L04AG08 • Antineoplastic and immunomodulating agents | Immunosuppressants | Monoclonal antibodies

23025.52 RON

C2

P-RF

OCREVUS 300mg perfusive solution concentrate EGIS ORIGINAL
MEDICINE

Chemical substance: ocrelizumab

ATC code: L04AA36 • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants

P-RF

Results for the substance ocrelizumab:

L04AA36 - ocrelizumab (Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants)

L04AG08 - ocrelizumab (Antineoplastic and immunomodulating agents | Immunosuppressants | Monoclonal antibodies)